Design Therapeutics, Inc. (DSGN): Shares Outstanding

Annual figures by period end, from SEC filings.

60.40M
As of 2025-12-31
62.58M
As of 2026-06-30
+2.6%
3-year compound annual growth
+30.5%
5-year compound annual growth
2020-12-31: 15.96M2021-12-31: 55.44M2022-12-31: 55.90M2023-12-31: 56.47M2024-12-31: 56.75M2025-12-31: 60.40M60.40M
2020-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3160.40M+6.4%2026-03-09, Balance as of period end
2024-12-3156.75M+0.5%2026-03-09, Balance as of period end
2023-12-3156.47M+1.0%2025-03-10, Balance as of period end
2022-12-3155.90M+0.8%2024-03-19, Balance as of period end
2021-12-3155.44M+247.4%2023-03-14, Balance as of period end
2020-12-3115.96Mn/a2022-03-10, Balance as of period end